Disclosed is the use of a preparation of whole killed bacteria of one or more pathogenic bacterial species in the manufacture of a medicament for preventing or treating a cancer located in a specific organ or tissue in a subject, wherein the preparation elicits an immune response in the subject, and wherein the pathogenic bacterial species is pathogenic in the corresponding specific organ or tissue in a healthy subject. .
